Rhumbline Advisers grew its holdings in Danaher Co. (NYSE:DHR) by 0.3% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 1,115,170 shares of the conglomerate’s stock after acquiring an additional 3,000 shares during the quarter. Rhumbline Advisers’ holdings in Danaher were worth $110,045,000 at the end of the most recent reporting period.

Several other institutional investors have also made changes to their positions in DHR. Mount Yale Investment Advisors LLC bought a new position in shares of Danaher during the first quarter worth about $103,000. IMS Capital Management bought a new position in shares of Danaher during the second quarter worth about $107,000. BerganKDV Wealth Management LLC bought a new position in shares of Danaher during the second quarter worth about $111,000. Zions Bancorporation bought a new position in shares of Danaher during the first quarter worth about $123,000. Finally, Kaizen Advisory LLC grew its holdings in shares of Danaher by 150.3% during the second quarter. Kaizen Advisory LLC now owns 1,464 shares of the conglomerate’s stock worth $144,000 after buying an additional 879 shares in the last quarter. Institutional investors own 76.51% of the company’s stock.

In related news, insider Thomas Patrick Joyce, Jr. sold 104,913 shares of the stock in a transaction that occurred on Tuesday, July 31st. The stock was sold at an average price of $101.88, for a total transaction of $10,688,536.44. Following the completion of the transaction, the insider now directly owns 276,438 shares of the company’s stock, valued at $28,163,503.44. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, SVP Robert S. Lutz sold 14,555 shares of the stock in a transaction that occurred on Tuesday, July 24th. The shares were sold at an average price of $103.93, for a total value of $1,512,701.15. Following the transaction, the senior vice president now directly owns 18,044 shares of the company’s stock, valued at $1,875,312.92. The disclosure for this sale can be found here. Insiders have sold 196,875 shares of company stock valued at $20,246,147 over the last three months. Insiders own 11.90% of the company’s stock.

A number of research firms recently issued reports on DHR. Zacks Investment Research downgraded Danaher from a “buy” rating to a “hold” rating in a report on Tuesday, July 24th. Morgan Stanley increased their price objective on Danaher from $120.00 to $122.00 and gave the stock an “overweight” rating in a report on Friday, July 20th. Royal Bank of Canada increased their price objective on Danaher to $107.00 and gave the stock a “positive” rating in a report on Thursday, July 19th. They noted that the move was a valuation call. Bank of America set a $113.00 price objective on Danaher and gave the stock a “buy” rating in a report on Thursday, July 19th. Finally, ValuEngine upgraded Danaher from a “hold” rating to a “buy” rating in a report on Thursday, July 12th. Two equities research analysts have rated the stock with a hold rating and sixteen have given a buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and a consensus target price of $108.31.

Shares of NYSE DHR opened at $100.33 on Friday. Danaher Co. has a 52 week low of $79.10 and a 52 week high of $106.08. The company has a quick ratio of 1.07, a current ratio of 1.50 and a debt-to-equity ratio of 0.41. The company has a market cap of $71.34 billion, a P/E ratio of 24.90, a P/E/G ratio of 1.95 and a beta of 1.04.

Danaher (NYSE:DHR) last issued its quarterly earnings results on Thursday, July 19th. The conglomerate reported $1.15 EPS for the quarter, beating the consensus estimate of $1.09 by $0.06. Danaher had a return on equity of 11.55% and a net margin of 13.84%. The firm had revenue of $4.98 billion during the quarter, compared to analysts’ expectations of $4.91 billion. During the same period in the prior year, the firm posted $0.99 earnings per share. The business’s quarterly revenue was up 10.4% compared to the same quarter last year. equities research analysts anticipate that Danaher Co. will post 4.49 EPS for the current year.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides laser scanning, compound, surgical, and other stereo microscopes. This segment also offers filtration, separation, and purification technologies to the biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial sectors.

Further Reading: Stock Symbols Definition, Examples, Lookup

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.